| S. No. | Company | No. of Patents | Name of the Drug | Class |
|---|---|---|---|---|
| 1 | GSK | 4 | Agenerase | PI |
| 2 | GSK | 2 | Lexiva | PI |
| 3 | GSK | 4 | Ziagen | NRTIs |
| 4 | GSK | 4 | Epzicom | NRTIs |
| 5 | GSK | 2 | Epivir | NRTIs |
| 6 | GSK | 1 | Combivir | NRTIs |
| 7 | BMS | 2 | Reyataz | PI |
| 8 | BMS | 2 | Sustiva | NNRTIs |
| 9 | Tibotec | 3 | Prezista | PI |
| 10 | Tibotec | 2 | Intelence | NNRTIs |
| 11 | Merck | 3 | Isentress | HIV integrase strand transfer inhibitors |
| 12 | Merck | 2 | Crixivan | PI |
| 13 | Abbott | 20 | Kaletra | PI |
| 14 | Agouron | 3 | Viracept | PI |
| 15 | Agouron | 2 | Rescriptor | NNRTIs |
| 16 | Roche | 1 | Invirase | PI |
| 17 | Roche | 3 | Fuzeon | Fusion Inhibitor |
| 18 | BI | 4 | Aptivus | PI |
| 19 | BI | 1 | Viramune | NNRTIs |
| 20 | Gilead | 15 | Atripla | NRTIs |
| 21 | Gilead | 10 | Truvada | NRTIs |
| 22 | Pfizer | 3 | Selzentry | Entry Inhibitors-CCR5 co-receptor antagonist |
| Total | 93 | |||